Therapy News and Research

RSS

Caregivers of cancer patients can manage end-of-life treatment, decisions with help from support team

Many caregivers of terminal cancer patients suffer depression and report regret and guilt from feeling they could have done more to eliminate side effects and relieve the pain.

8 Jul 2014

New mechanism of chemotherapy resistance in triple-negative inflammatory breast cancer

Researchers at Roswell Park Cancer Institute (RPCI) have identified a mechanism of breast cancer cells that leads to chemotherapy resistance in inflammatory breast cancer.

8 Jul 2014

Dental pulp stem cells can protect retinal ganglion cells from death following injury

Researchers at the University of Birmingham, UK, led by Dr. Ben Scheven, Dr. Wendy Leadbeater and Ben Mead have discovered that stem cells isolated from the teeth, termed dental pulp stem cells (DPSC), can protect retinal ganglion cells (RGCs) from death following injury and promote regeneration of their axons along the optic nerve.

7 Jul 2014

$FDA grants Breakthrough Therapy status to Novartis' CTL019 for treatment of relapsed/refractory ALL$

FDA grants Breakthrough Therapy status to Novartis' CTL019 for treatment of relapsed/refractory ALL

Novartis announced today that the United States Food and Drug Administration has granted Breakthrough Therapy status to CTL019, an investigational chimeric antigen receptor (CAR) therapy for the treatment of pediatric and adult patients with relapsed/refractory acute lymphoblastic leukemia (r/r ALL).

7 Jul 2014

Penn’s immunotherapy receives FDA's Breakthrough Therapy designation for ALL treatment

A University of Pennsylvania-developed personalized immunotherapy has been awarded the U.S. Food and Drug Administration's Breakthrough Therapy designation for the treatment of relapsed and refractory adult and pediatric acute lymphoblastic leukemia (ALL).

7 Jul 2014

Menopause toolkit launched to help primary care physicians

A practical toolkit to help primary care physicians diagnose and manage the menopause has been released, which could potentially revolutionise menopausal treatment.

7 Jul 2014

AutoGenomics, Genomas sign agreement to develop DNA-guided diagnostic systems

AutoGenomics, Inc, a leader in automated microarray technology for molecular diagnostics, and Genomas, a biomedical company enabling DNA-guided medicine for personal healthcare, announced today that they have signed an agreement to jointly develop genetic tests and DNA-guided diagnostic systems for optimal selection of statins and for improved delivery of statin therapy for the treatment of cardiovascular disease, obesity and diabetes.

7 Jul 2014

Investigators report effects of internet based treatment on obsessive symptoms

A group of German investigators reports on the affects of internet based treatment on obsessive symptoms in the current issue of Psychotherapy and Psychosomatics.

7 Jul 2014

Treating ulcerative colitis and Crohn’s disease

Ulcerative colitis and Crohn’s disease are idiopathic (we don’t know the cause) inflammatory diseases (IBD) of the colon and/or small bowel. They are chronic in that we do not have a medical cure and are differentiated from IBS (irritable bowel syndrome) by inflammation that causes ulcerations of the GI tract.

7 Jul 2014

Study analyzes difference between day hospital and inpatient stay in depression

A study published in the current issue of Psychotherapy and Psychosomatics has analyzed the difference between day hospital and inpatient stay in depression.

7 Jul 2014

Global toolkit for managing menopause

Created at Monash University, the world's first toolkit is designed for GPs to use with women from the age of 40. Thought to be the first of its kind, researchers say the toolkit has the potential to help manage menopausal conditions for women globally.

7 Jul 2014

Researchers confirm anecdotal information on Alzheimer's disease and cerebrovascular disease

Researchers from the Sanders-Brown Center on Aging at the University of Kentucky have been able to confirm anecdotal information on patients with both Alzheimer's disease (AD) and cerebrovascular disease (CVD) using mouse models in two different studies.

4 Jul 2014

Research roundup: 20M gain insurance, coverage's effect on surgery choices; opioid use by service members

This report aims to help readers understand recently announced enrollment numbers, as well as other numbers that have received less attention, and assess their importance for the future of the ACA and our health care system. .

4 Jul 2014

Orthopedic surgeon offers critical insights on total knee replacement surgery

In 2010, Bonnie Egbert, a veteran of more than 20 marathons, had to quit running due to excruciating pain caused by her right knee joint rubbing bone on bone.

4 Jul 2014

TxCell announces launch of POSITIVE project to automate manufacturing process for Ovasave

TxCell SA, a biotech developing innovative, personalized cell-based immunotherapies using antigen-specific regulatory T-cells (Ag-Tregs) for chronic inflammatory and autoimmune diseases, announces today the launch of, and funding awarded to, the POSITIVE project in collaboration with the Gene and Cell therapy Unit (UTCG) developing new antiviral cell-based immunotherapies and Biosafe, a Swiss private company, a developer of innovative solutions for cell processing.

4 Jul 2014

Two life-threatening adverse drug reactions that affect the skin likely to recur

Individuals who are hospitalized for the skin conditions of Stevens-Johnson syndrome and toxic epidermal necrolysis appear to have a high risk of recurrence, according to a study in the June 4 issue of JAMA.

4 Jul 2014

Researchers confirm anecdotal information on patients with Alzheimer's disease, CVD

4 Jul 2014

Pneumonia patients treated with azithromycin face lower risk of death, slightly increased risk of heart attack

In a study that included nearly 65,000 older patients hospitalized with pneumonia, treatment that included azithromycin compared with other antibiotics was associated with a significantly lower risk of death and a slightly increased risk of heart attack, according to a study in the June 4 issue of JAMA.

4 Jul 2014

Preventive placement of ICDs improves survival in patients with less severe heart failure

An examination of the benefit of preventive placement of implantable cardioverter-defibrillators (ICDs) in patients with a less severe level of heart failure, a group not well represented in clinical trials, finds significantly better survival at three years than that of similar patients with no ICD, according to a study in the June 4 issue of JAMA.

4 Jul 2014

Promising new drug for metabolic syndrome

University of Utah researchers have discovered that an enzyme involved in intracellular signaling plays a crucial role in developing metabolic syndrome, a finding that has a U of U spinoff company developing a drug to potentially treat the condition.

4 Jul 2014

Therapy News and Research

Caregivers of cancer patients can manage end-of-life treatment, decisions with help from support team

New mechanism of chemotherapy resistance in triple-negative inflammatory breast cancer

Dental pulp stem cells can protect retinal ganglion cells from death following injury

FDA grants Breakthrough Therapy status to Novartis' CTL019 for treatment of relapsed/refractory ALL

Penn’s immunotherapy receives FDA's Breakthrough Therapy designation for ALL treatment

Menopause toolkit launched to help primary care physicians

AutoGenomics, Genomas sign agreement to develop DNA-guided diagnostic systems

Investigators report effects of internet based treatment on obsessive symptoms

Treating ulcerative colitis and Crohn’s disease

Study analyzes difference between day hospital and inpatient stay in depression

Global toolkit for managing menopause

Researchers confirm anecdotal information on Alzheimer's disease and cerebrovascular disease

Research roundup: 20M gain insurance, coverage's effect on surgery choices; opioid use by service members

Orthopedic surgeon offers critical insights on total knee replacement surgery

TxCell announces launch of POSITIVE project to automate manufacturing process for Ovasave

Two life-threatening adverse drug reactions that affect the skin likely to recur

Researchers confirm anecdotal information on patients with Alzheimer's disease, CVD

Pneumonia patients treated with azithromycin face lower risk of death, slightly increased risk of heart attack

Preventive placement of ICDs improves survival in patients with less severe heart failure

Promising new drug for metabolic syndrome

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News